MHRA reclassifies two products to general sale
This article was originally published in Scrip
Executive Summary
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has reclassified two products from pharmacy to general sales list: nicotine nasal spray, 0.5mg nicotine per spray, as a smoking cessation aid in adults and children over 12 years of age, and benzocaine throat spray, 1mg per spray, for the relief of sore throat pain in adults and children over six.